Waseem Gul. Ph.D., C. Chem, Associate Director of Research

Dr. Gul is responsible for the synthesis of a variety of standards and internal standards and new chemical entities, as well as structure modification of drug substances used in the laboratory’s drug discovery and development activities for treatment of a variety of diseases. The compounds are characterized by spectroscopic analysis (1H-NMR, 13C-NMR, 2D-NMR such as COSY, HMQC, HMBC etc.,) using NMR equipment (300, 400, 500 MHz), LC/MS, HREIMS, GC/MS, IR, UV and X-ray Crystallography studies. Dr. Gul is also involved in the development of procedures for the analysis of drugs and drug metabolites in biological specimens using a variety of analytical equipments e.g. GC/MS, HREIMS, LC/MS, HPLC etc. and assumes responsibilities in research areas directed towards solving problems presented by our clients.

Dr. Gul has Bachelor in Science (chemistry), Master in Science (organic chemistry) from the University of Peshawar, and Ph.D. in chemistry from Gomal University in Pakistan. All Ph.D. work was done at the University of Calgary, AB, Canada in Professor M.H. Benn’s group.

Prior to employment with ELI in 2003, Dr. Gul served as senior chemist at AGAT Laboratories, Calgary, AB, Canada, and postdoctoral research associate at the University of Calgary, AB, Canada and University of Mississippi, USA.

Dr. Gul has more than thirty scientific publications and more than thirty- five presentations at scientific meetings of professional societies. He currently holds three issued patents (compositions for the treatment of cancer and others in the diagnostics area). Other patent applications are currently pending. His awards include American Crystallographic Association Travel Award to attend Annual Meeting, St. Louis, Missouri, 1997, invited entry in Who’s Who in the World, 2009, and Research Support Awards from National Institute of Health, (Composition for Prevention/Prophylactic Treatment of Poison Ivy Contact Dermatitis, Phase I, 2006-2007) and (Transmucosal Intra-Oral Drug Delivery System for THC, Phase II, 2008-2010). He is a member of the American Chemical Society, Society of Forensic Toxicologists, Association of the Chemical Profession of Ontario and affiliate member of the International Union of Pure and Applied Chemistry and is a regular reviewer for many journals.